{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:00Z","timestamp":1791475320527,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1124\/jpet.107.127035","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T01:12:06Z","timestamp":1187399526000},"page":"488-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-\u03b1 in the Rat"],"prefix":"10.1016","volume":"323","author":[{"given":"Eduardo","family":"Candelario-Jalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Grossetete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Y.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd L.","family":"Fiebich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.127035_bib1","doi-asserted-by":"crossref","unstructured":"Akundi RS, Candelario-Jalil E, Hess S, Hull M, Lieb K, Gebicke-Haerter PJ, and Fiebich BL (2005) Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 51: 199\u2013208.","DOI":"10.1002\/glia.20198"},{"key":"10.1124\/jpet.107.127035_bib2","unstructured":"Badie B, Schartner JM, Hagar AR, Prabakaran S, Peebles TR, Bartley B, Lapsiwala S, Resnick DK, and Vorpahl J (2003) Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. Clin Cancer Res 9: 872\u2013877."},{"key":"10.1124\/jpet.107.127035_bib3","doi-asserted-by":"crossref","unstructured":"Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, Alvarez D, Al-Dalain S, Martinez G, Leon OS, and Springer JE (2003) Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem 86: 545\u2013555.","DOI":"10.1046\/j.1471-4159.2003.01812.x"},{"key":"10.1124\/jpet.107.127035_bib4","doi-asserted-by":"crossref","unstructured":"Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, Leon OS, and Fiebich BL (2007) Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 100: 1108\u20131120.","DOI":"10.1111\/j.1471-4159.2006.04280.x"},{"key":"10.1124\/jpet.107.127035_bib5","doi-asserted-by":"crossref","unstructured":"Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De CD, Ucchino S, Spigonardo F, Marchetti A, Buttitta F, Paloscia L, et al. (2005) Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 25: 1925\u20131931.","DOI":"10.1161\/01.ATV.0000177814.41505.41"},{"key":"10.1124\/jpet.107.127035_bib6","doi-asserted-by":"crossref","unstructured":"de Vries HE, Blom-Roosemalen MC, van OM, de Boer AG, van Berkel TJ, Breimer DD, and Kuiper J (1996) The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 64: 37\u201343.","DOI":"10.1016\/0165-5728(95)00148-4"},{"key":"10.1124\/jpet.107.127035_bib7","doi-asserted-by":"crossref","unstructured":"Fernandez-Checa JC, and Kaplowitz N (1990) The use of monochlorobimane to determine hepatic GSH levels and synthesis. Anal Biochem 190: 212\u2013219.","DOI":"10.1016\/0003-2697(90)90183-A"},{"key":"10.1124\/jpet.107.127035_bib8","doi-asserted-by":"crossref","unstructured":"Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, Chiappelli F, Schweitzer ES, Shapshak P, Weinand M, et al. (1997) TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med 3: 553\u2013564.","DOI":"10.1007\/BF03401701"},{"key":"10.1124\/jpet.107.127035_bib9","doi-asserted-by":"crossref","unstructured":"Fridman R, Toth M, Chvyrkova I, Meroueh SO, and Mobashery S (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22: 153\u2013166.","DOI":"10.1023\/A:1023091214123"},{"key":"10.1124\/jpet.107.127035_bib10","doi-asserted-by":"crossref","unstructured":"Gasche Y, Copin JC, Sugawara T, Fujimura M, and Chan PH (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21: 1393\u20131400.","DOI":"10.1097\/00004647-200112000-00003"},{"key":"10.1124\/jpet.107.127035_bib11","doi-asserted-by":"crossref","unstructured":"Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, and Lipton SA (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186\u20131190.","DOI":"10.1126\/science.1073634"},{"key":"10.1124\/jpet.107.127035_bib12","doi-asserted-by":"crossref","unstructured":"Gurney KJ, Estrada EY, and Rosenberg GA (2006) Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23: 87\u201396.","DOI":"10.1016\/j.nbd.2006.02.006"},{"key":"10.1124\/jpet.107.127035_bib13","doi-asserted-by":"crossref","unstructured":"Hawkins BT, and Davis TP (2005) The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 57: 173\u2013185.","DOI":"10.1124\/pr.57.2.4"},{"key":"10.1124\/jpet.107.127035_bib14","doi-asserted-by":"crossref","unstructured":"Hewett SJ, Bell SC, and Hewett JA (2006) Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol Ther 112: 335\u2013357.","DOI":"10.1016\/j.pharmthera.2005.04.011"},{"key":"10.1124\/jpet.107.127035_bib15","doi-asserted-by":"crossref","unstructured":"Kadurugamuwa JL, Hengstler B, and Zak O (1989) Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis 159: 26\u201334.","DOI":"10.1093\/infdis\/159.1.26"},{"key":"10.1124\/jpet.107.127035_bib16","doi-asserted-by":"crossref","unstructured":"Kamencic H, Lyon A, Paterson PG, and Juurlink BH (2000) Monochlorobimane fluorometric method to measure tissue glutathione. Anal Biochem 286: 35\u201337.","DOI":"10.1006\/abio.2000.4765"},{"key":"10.1124\/jpet.107.127035_bib17","doi-asserted-by":"crossref","unstructured":"Kinugasa Y, Hatori M, Ito H, Kurihara Y, Ito D, and Nagumo M (2004) Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. Clin Exp Metastasis 21: 737\u2013745.","DOI":"10.1007\/s10585-005-1190-x"},{"key":"10.1124\/jpet.107.127035_bib18","doi-asserted-by":"crossref","unstructured":"Kyrkanides S, Moore AH, Olschowka JA, Daeschner JC, Williams JP, Hansen JT, and Kerry OM (2002) Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res 104: 159\u2013169.","DOI":"10.1016\/S0169-328X(02)00353-4"},{"key":"10.1124\/jpet.107.127035_bib19","doi-asserted-by":"crossref","unstructured":"Mark KS, Trickler WJ, and Miller DW (2001) Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 297: 1051\u20131058.","DOI":"10.1016\/S0022-3565(24)29632-4"},{"key":"10.1124\/jpet.107.127035_bib20","doi-asserted-by":"crossref","unstructured":"Morin I, Li WQ, Su S, Ahmad M, and Zafarullah M (1999) Induction of stromelysin gene expression by tumor necrosis factor alpha is inhibited by dexamethasone, salicylate, and N-acetylcysteine in synovial fibroblasts. J Pharmacol Exp Ther 289: 1634\u20131640.","DOI":"10.1016\/S0022-3565(24)38315-6"},{"key":"10.1124\/jpet.107.127035_bib21","doi-asserted-by":"crossref","unstructured":"Nagase H, Fields CG, and Fields GB (1994) Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J Biol Chem 269: 20952\u201320957.","DOI":"10.1016\/S0021-9258(17)31914-2"},{"key":"10.1124\/jpet.107.127035_bib22","doi-asserted-by":"crossref","unstructured":"Ogata Y, Enghild JJ, and Nagase H (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267: 3581\u20133584.","DOI":"10.1016\/S0021-9258(19)50563-4"},{"key":"10.1124\/jpet.107.127035_bib23","doi-asserted-by":"crossref","unstructured":"Pan MR, Chuang LY, and Hung WC (2001) Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells. FEBS Lett 508: 365\u2013368.","DOI":"10.1016\/S0014-5793(01)03118-0"},{"key":"10.1124\/jpet.107.127035_bib24","doi-asserted-by":"crossref","unstructured":"Paoletti AM, Piccirilli S, Costa N, Rotiroti D, Bagetta G, and Nistico G (1998) Systemic administration of N-omega-nitro-l-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat. Exp Neurol 149: 349\u2013355.","DOI":"10.1006\/exnr.1997.6741"},{"key":"10.1124\/jpet.107.127035_bib25","doi-asserted-by":"crossref","unstructured":"Patlak CS, Blasberg RG, and Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3: 1\u20137.","DOI":"10.1038\/jcbfm.1983.1"},{"key":"10.1124\/jpet.107.127035_bib26","doi-asserted-by":"crossref","unstructured":"Pavlovic S, Du B, Sakamoto K, Khan KM, Natarajan C, Breyer RM, Dannenberg AJ, and Falcone DJ (2006) Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J Biol Chem 281: 3321\u20133328.","DOI":"10.1074\/jbc.M506846200"},{"key":"10.1124\/jpet.107.127035_bib27","doi-asserted-by":"crossref","unstructured":"Pepicelli O, Fedele E, Berardi M, Raiteri M, Levi G, Greco A, Ajmone-Cat MA, and Minghetti L (2005) Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-d-aspartate receptors in rat hippocampus. J Neurochem 93: 1561\u20131567.","DOI":"10.1111\/j.1471-4159.2005.03150.x"},{"key":"10.1124\/jpet.107.127035_bib28","doi-asserted-by":"crossref","unstructured":"Ramilo O, Saez-Llorens X, Mertsola J, Jafari H, Olsen KD, Hansen EJ, Yoshinaga M, Ohkawara S, Nariuchi H, and McCracken GH Jr (1990) Tumor necrosis factor alpha\/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med 172: 497\u2013507.","DOI":"10.1084\/jem.172.2.497"},{"key":"10.1124\/jpet.107.127035_bib29","doi-asserted-by":"crossref","unstructured":"Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, and Gearing A (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893: 104\u2013112.","DOI":"10.1016\/S0006-8993(00)03294-7"},{"key":"10.1124\/jpet.107.127035_bib30","doi-asserted-by":"crossref","unstructured":"Rosenberg GA, Estrada EY, and Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29: 2189\u20132195.","DOI":"10.1161\/01.STR.29.10.2189"},{"key":"10.1124\/jpet.107.127035_bib31","doi-asserted-by":"crossref","unstructured":"Rosenberg GA, Estrada EY, Dencoff JE, and Stetler-Stevenson WG (1995) Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 703: 151\u2013155.","DOI":"10.1016\/0006-8993(95)01089-0"},{"key":"10.1124\/jpet.107.127035_bib32","doi-asserted-by":"crossref","unstructured":"Schmidley JW, Dadson J, Iyer RS, and Salomon RG (1992) Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2. Prostaglandins Leukot Essent Fatty Acids 47: 105\u2013110.","DOI":"10.1016\/0952-3278(92)90145-9"},{"key":"10.1124\/jpet.107.127035_bib33","doi-asserted-by":"crossref","unstructured":"Sood R, Taheri S, Estrada EY, and Rosenberg GA (2007) Quantitative evaluation of the effect of propylene glycol on BBB permeability. J Magn Reson Imaging 25: 39\u201347.","DOI":"10.1002\/jmri.20802"},{"key":"10.1124\/jpet.107.127035_bib34","unstructured":"Ting P (1990) Indomethacin attenuates early postischemic vasogenic edema and cerebral injury. Adv Neurol 52: 119\u2013126."},{"key":"10.1124\/jpet.107.127035_bib35","doi-asserted-by":"crossref","unstructured":"Trickler WJ, Mayhan WG, and Miller DW (2005) Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Res 1048: 24\u201331.","DOI":"10.1016\/j.brainres.2005.04.028"},{"key":"10.1124\/jpet.107.127035_bib36","doi-asserted-by":"crossref","unstructured":"Tsao N, Hsu HP, Wu CM, Liu CC, and Lei HY (2001) Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 50: 812\u2013821.","DOI":"10.1099\/0022-1317-50-9-812"},{"key":"10.1124\/jpet.107.127035_bib37","doi-asserted-by":"crossref","unstructured":"Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Marmer BL, Grant GA, Bauer EA, and Goldberg GI (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad SciUSA 84: 6725\u20136729.","DOI":"10.1073\/pnas.84.19.6725"},{"key":"10.1124\/jpet.107.127035_bib38","doi-asserted-by":"crossref","unstructured":"Yang GY, Gong C, Qin Z, Liu XH, and Lorris BA (1999) Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 69: 135\u2013143.","DOI":"10.1016\/S0169-328X(99)00007-8"},{"key":"10.1124\/jpet.107.127035_bib39","doi-asserted-by":"crossref","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, and Rosenberg GA (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697\u2013709.","DOI":"10.1038\/sj.jcbfm.9600375"},{"key":"10.1124\/jpet.107.127035_bib40","doi-asserted-by":"crossref","unstructured":"Zhang JW and Gottschall PE (1997) Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 76: 15\u201320.","DOI":"10.1016\/S0165-0270(97)00065-4"},{"key":"10.1124\/jpet.107.127035_bib41","doi-asserted-by":"crossref","unstructured":"Zuckerman SL, Mirro R, Armstead WM, Shibata M, and Leffler CW (1994) Indomethacin reduces ischemia-induced alteration of blood-brain barrier transport in piglets. Am J Physiol 266: H2198\u2013H2203.","DOI":"10.1152\/ajpheart.1994.266.6.H2198"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.127035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:26:08Z","timestamp":1740003968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524341357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0022356524341357"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.127035","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-\u03b1 in the Rat","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.127035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}